Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Income-Before-Tax" stands at 12.34 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Sumitomo Dainippon Pharma Co Ltd's first quarter result of 11.93 Billion JPY for the item "Income Before Tax" represents an increase of 286.00 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 11.93 Billion JPY for the item "Income Before Tax" represents a decrease of -30.64 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 12.34 Billion JPY for the item "Income Before Tax" represents a decrease of -29.93 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 287.20 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 287.20 Billion Japanese Yens.
The 3 year change is -109.27 Billion Japanese Yens.
The 5 year change is -56.68 Billion Japanese Yens.
The 10 year change is -20.86 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Income Before Tax | 905,699,262,464.00 |
![]() | Johnson & Johnson - Income Before Tax | 486,508,953,600.00 |
![]() | AbbVie Inc - Income Before Tax | 399,570,305,024.00 |
![]() | Roche Holding AG - Income Before Tax | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Income Before Tax | 280,205,508,085.11 |